Kenneth M Cohen - Net Worth and Insider Trading

Kenneth M Cohen Net Worth

The estimated net worth of Kenneth M Cohen is at least $656,765 dollars as of 2024-11-13. Kenneth M Cohen is the Member of 10% owner group of Core Lithium Corp and owns about 656,755 shares of Core Lithium Corp (CORX) stock worth over $656,755. Kenneth M Cohen is the Director of MabVax Therapeutics Holdings Inc and owns about 450 shares of MabVax Therapeutics Holdings Inc (MBVXQ) stock worth over $10. Kenneth M Cohen is also the Director of DMK Pharmaceuticals Corp and owns about 42 shares of DMK Pharmaceuticals Corp (DMKPQ) stock worth over $0. Details can be seen in Kenneth M Cohen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth M Cohen has not made any transactions after 2015-05-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kenneth M Cohen

To

Kenneth M Cohen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kenneth M Cohen owns 3 companies in total, including MabVax Therapeutics Holdings Inc (MBVXQ) , DMK Pharmaceuticals Corp (DMKPQ) , and RespireRx Pharmaceuticals Inc (RSPI) .

Click here to see the complete history of Kenneth M Cohen’s form 4 insider trades.

Insider Ownership Summary of Kenneth M Cohen

Ticker Comapny Transaction Date Type of Owner
MBVXQ MabVax Therapeutics Holdings Inc 2018-04-02 director
DMKPQ DMK Pharmaceuticals Corp 2011-01-12 director
RSPI RespireRx Pharmaceuticals Inc 2013-03-22 other: Member of 10% owner group

Kenneth M Cohen Latest Holdings Summary

Kenneth M Cohen currently owns a total of 3 stocks. Among these stocks, Kenneth M Cohen owns 656,755 shares of Core Lithium Corp (CORX) as of March 22, 2013, with a value of $656,755 and a weighting of 100%. Kenneth M Cohen owns 450 shares of MabVax Therapeutics Holdings Inc (MBVXQ) as of May 22, 2015, with a value of $10 and a weighting of 0%. Kenneth M Cohen also owns 42 shares of DMK Pharmaceuticals Corp (DMKPQ) as of January 12, 2011, with a value of $0 and a weighting of 0%.

Latest Holdings of Kenneth M Cohen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CORX Core Lithium Corp 2013-03-22 656,755 1.00 656,755
MBVXQ MabVax Therapeutics Holdings Inc 2015-05-22 450 0.02 10
DMKPQ DMK Pharmaceuticals Corp 2011-01-12 42 0.00 0

Holding Weightings of Kenneth M Cohen


Kenneth M Cohen Form 4 Trading Tracker

According to the SEC Form 4 filings, Kenneth M Cohen has made a total of 0 transactions in Core Lithium Corp (CORX) over the past 5 years. The most-recent trade in Core Lithium Corp is the sale of 0 shares on March 22, 2013, which brought Kenneth M Cohen around $0.

According to the SEC Form 4 filings, Kenneth M Cohen has made a total of 0 transactions in MabVax Therapeutics Holdings Inc (MBVXQ) over the past 5 years. The most-recent trade in MabVax Therapeutics Holdings Inc is the acquisition of 158 shares on May 22, 2015, which cost Kenneth M Cohen around $8,050.

According to the SEC Form 4 filings, Kenneth M Cohen has made a total of 0 transactions in DMK Pharmaceuticals Corp (DMKPQ) over the past 5 years. The most-recent trade in DMK Pharmaceuticals Corp is the sale of 0 shares on January 12, 2011, which brought Kenneth M Cohen around $0.

Insider Trading History of Kenneth M Cohen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kenneth M Cohen Trading Performance

GuruFocus tracks the stock performance after each of Kenneth M Cohen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth M Cohen is -36.68%. GuruFocus also compares Kenneth M Cohen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth M Cohen within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kenneth M Cohen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kenneth M Cohen

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.22 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -1.07 LIMIT LIMIT LIMIT LIMIT LIMIT

Kenneth M Cohen Ownership Network

Ownership Network List of Kenneth M Cohen

No Data

Ownership Network Relation of Kenneth M Cohen

Insider Network Chart

Kenneth M Cohen Owned Company Details

What does MabVax Therapeutics Holdings Inc do?

Who are the key executives at MabVax Therapeutics Holdings Inc?

Kenneth M Cohen is the director of MabVax Therapeutics Holdings Inc. Other key executives at MabVax Therapeutics Holdings Inc include CHIEF FINANCIAL OFFICER & SECR Gregory P Hanson , EXEC. VP & R AND D Paul W Maffuid , and 10 percent owner David S Wetherell .

MabVax Therapeutics Holdings Inc (MBVXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MabVax Therapeutics Holdings Inc (MBVXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MabVax Therapeutics Holdings Inc (MBVXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MabVax Therapeutics Holdings Inc (MBVXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

MabVax Therapeutics Holdings Inc Insider Transactions

No Available Data

Kenneth M Cohen Mailing Address

Above is the net worth, insider trading, and ownership report for Kenneth M Cohen. You might contact Kenneth M Cohen via mailing address: 12750 High Bluff Drive, Suite 310, San Diego Ca 92130.